VF
AKCA

Virtu Financial’s Akcea Therapeutics Inc AKCA Stock Holding History

Virtu Financial’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,722
Closed -$207K – 2444
2018
Q2 		$207K Sell
8,722
-3,849
-31% -$91.9K 0.01% 1487
2018
Q1 		$322K Buy
+12,571
New +$271K 0.02% 1006
2017
Q4 		– Sell
-11,898
Closed -$329K – 3255
2017
Q3 		$329K Buy
+11,898
New +$220K 0.02% 1297

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's AKCA Position: Q3 2018 in Review

Virtu Financial sold out of Akcea Therapeutics Inc (AKCA) in Q3 2018, closing a stake of 8,722 shares — an estimated $207K sold.

Virtu Financial first reported a position in AKCA in Q3 2017 and held it in 3 quarters. The position peaked at $329K in Q3 2017. 65 funds tracked by Wall St. Rank hold AKCA as of Q3 2018.

  • Virtu Financial reported no remaining Akcea Therapeutics Inc position as of Q3 2018 after selling out during the quarter.
  • Virtu Financial sold 8,722 Akcea Therapeutics Inc shares in Q3 2018, an estimated $207K.
  • Virtu Financial first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 3 quarters.
  • Virtu Financial's Akcea Therapeutics Inc position peaked at $329K in Q3 2017.
  • 65 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q3 2018.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.